Tumor heterogeneity and circulating tumor cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Letters

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2016.02.024PMID 26902424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.

  2015cited by this paper
• Systems Biology With High-Throughput Sequencing Reveals Genetic Mechanisms Underlying the Metabolic Syndrome in the Lyon Hypertensive Rat

  2015cited by this paper
• Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

  2015cited by this paper
• Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab

  2015cited by this paper
• Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood

  2015cited by this paper
• Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

  2015cited by this paper
• Recent advances and current issues in single-cell sequencing of tumors.

  2015cited by this paper
• The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

  2015cited by this paper
• KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.

  2015cited by this paper
• Non‐invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients

  2015cited by this paper
• Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

  2015cited by this paper
• Translational Implications of Tumor Heterogeneity

  2015cited by this paper
• Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue

  2015cited by this paper
• High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

  2015cited by this paper
• A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus

  2015cited by this paper
• Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

  2015cited by this paper
• Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine

  2014cited by this paper
• Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing

  2014cited by this paper
• Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.

  2014cited by this paper
• Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

  2014cited by this paper
• Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

  2014cited by this paper
• Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study

  2014cited by this paper
• KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer

  2014cited by this paper
• Nanostructure Embedded Microchips for Detection, Isolation, and Characterization of Circulating Tumor Cells

  2014cited by this paper
• Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

  2014cited by this paper
• Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

  2014cited by this paper
• Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow

  2014cited by this paper
• Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer

  2014cited by this paper
• Molecular and genetic diversity in the metastatic process of melanoma

  2014cited by this paper
• Circulating tumor cells in early bladder cancer: insight into micrometastatic disease

  2014cited by this paper
• Emerging techniques in molecular detection of circulating tumor cells

  2014cited by this paper
• Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer

  2014cited by this paper
• Tumor heterogeneity in the clinic: is it a real problem?

  2014cited by this paper
• Advances and critical concerns with the microfluidic enrichments of circulating tumor cells.

  2014cited by this paper
• Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

  2014cited by this paper
• Circulating tumor cells

  2014cited by this paper
• Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

  2013cited by this paper
• Personalized cancer treatment and the myth of KRAS wild-type colon tumors.

  2013cited by this paper
• Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

  2013cited by this paper
• Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system.

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.

  2013cited by this paper
• Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step

  2013cited by this paper
• Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status.

  2013cited by this paper
• Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer

  2013cited by this paper
• Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

  2013cited by this paper
• Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients

  2013cited by this paper
• Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification

  2013cited by this paper
• Circulating tumour cells: insights into tumour heterogeneity

  2013cited by this paper
• Detecting Circulating Tumor Cells: Current Challenges and New Trends

  2013cited by this paper
• Investigating intratumour heterogeneity by single-cell sequencing.

  2013cited by this paper
• Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

  2013cited by this paper
• Discordance between anaplastic lymphoma kinase status in primary non‐small‐cell lung cancers and their corresponding metastases

  2013cited by this paper
• Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma

  2013cited by this paper
• Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer

  2013cited by this paper
• Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.

  2013cited by this paper
• Cellular heterogeneity and molecular evolution in cancer.

  2013cited by this paper
• Cancer heterogeneity: implications for targeted therapeutics

  2013cited by this paper
• Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent

  2013cited by this paper
• KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

  2013cited by this paper
• Intratumor heterogeneity: evolution through space and time.

  2012cited by this paper
• Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

  2012cited by this paper
• Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance

  2012cited by this paper
• Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

  2012cited by this paper
• EMT and dissemination precede pancreatic tumor formation.

  2012cited by this paper
• EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

  2012cited by this paper
• Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Anoikis: an emerging hallmark in health and diseases

  2012cited by this paper
• Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.

  2012cited by this paper
• Circulating Tumor Cells

  2012cited by this paper
• Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications

  2012cited by this paper
• Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

  2012cited by this paper
• Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell

  2012cited by this paper
• Screening of Aptamers on Microfluidic Systems for Clinical Applications

  2012cited by this paper
• Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy.

  2012cited by this paper
• BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.

  2012cited by this paper
• Cancer theory faces doubts

  2011cited by this paper
• Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment

  2011cited by this paper
• Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer

  2011cited by this paper
• A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

  2011cited by this paper
• Mechanisms of endocrine resistance in breast cancer.

  2011cited by this paper
• Circulating tumor cells as a window on metastasis biology in lung cancer.

  2011cited by this paper
• Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

  2011cited by this paper
• Heterogeneity of KRAS Status May Explain the Subset of Discordant KRAS Status Between Primary and Metastatic Colorectal Cancer

  2011cited by this paper
• A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal Transition

  2011cited by this paper
• Future medical applications of single-cell sequencing in cancer

  2011cited by this paper
• Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

  2011cited by this paper
• KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

  2011cited by this paper
• Tumour evolution inferred by single-cell sequencing

  2011cited by this paper
• Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases

  2010cited by this paper
• Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

  2010cited by this paper
• American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

  2010cited by this paper
• Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

  2009cited by this paper

• Ratiometric SERS platform of dual bioprobes for stable detection of circulating tumor cells

  2026cites this paper
• Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges.

  2026cites this paper
• Tyramide signal amplification-based detection system: A novel approach to improve detection efficiency for circulating tumor cells.

  2025cites this paper
• Dual-receptor PET imaging of ovarian cancer using a 68Ga-labeled heterodimer targeting folate receptor and HER2.

  2025cites this paper
• Microfluidic chip coupled with photoelectrochemical/fluorescence dual-modal sensing system for the efficient enrichment and detection of circulating tumor cells.

  2025cites this paper
• Prediction of metastatic potential of heterogeneous pancreatic ductal adenocarcinoma through gradient-based algorithms.

  2025cites this paper
• Mutation profiling of KRAS and BRAF in primary tumors and circulating tumor cells of colorectal cancer patients using PNA-LNA molecular switch

  2025cites this paper
• Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility.

  2025cites this paper
• pH-Responsive gradient hydrophobic multidrug co-delivery microcapsules based on sodium alginate for enhanced tumor accumulation.

  2025cites this paper
• Liquid biopsy – a promising and effective method for surveying non-small cell lung cancer minimal residual diseases and anti-cancer drug response after treatment

  2025cites this paper
• Engineered Platelet for In Situ Natural Killer Cell Activation to Inhibit Tumor Recurrence.

  2024cites this paper
• Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

  2024cites this paper
• On the instability of particle-laden flows in channels with porous walls

  2024cites this paper
• A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation

  2024cites this paper
• Prediction of Neoadjuvant Chemoradiotherapy Sensitivity in Patients With Esophageal Squamous Cell Carcinoma Using CT-Based Radiomics Combined With Clinical Features

  2024cites this paper
• Multi-Scale Temporal Imaging: From Micro- and Meso- to Macro-scale-time Nuclear Medicine.

  2023cites this paper
• Circulating tumor cells in oral squamous cell carcinoma – Current status of its usefulness in clinical practice

  2023cites this paper
• Correlation between KRAS Mutation and CTLA-4 mRNA Expression in Circulating Tumour Cells: Clinical Implications in Colorectal Cancer

  2023cites this paper
• A novel thermoresponsive nano carrier matrix of hyaluronic acid, methotrexate and chitosan to target the cluster of differentiation 44 receptors in tumors.

  2023cites this paper
• Cancer metastasis: Molecular mechanisms and clinical perspectives.

  2023cites this paper
• Expression and clinical significance of tumor necrosis factor receptor-associated factor 1 in peripheral blood of patients with advanced lung cancer.

  2023cites this paper
• Research Progress of Circulating Tumor Cells in Advanced Gastric Cancer

  2023cites this paper
• Molecular profiles of single circulating tumor cells from early breast cancer patients with different lymph node statuses

  2022cites this paper
• State-of-the-art nanotechnologies for the detection, recovery, analysis and elimination of liquid biopsy components in cancer

  2022cites this paper
• Self-Reinforced Cancer Targeting (SRCT) Depending on Reciprocally Enhancing Feedback between Targeting and Therapy.

  2022cites this paper
• Application progress of liquid biopsy in gastric cancer

  2022cites this paper
• Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival

  2022cites this paper
• Surface-enhanced Raman spectroscopy for circulating biomarkers detection in clinical diagnosis

  2022cites this paper
• Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease

  2021cites this paper
• Real-Time Detection of Tumor Cells during Capture on a Filter Element Significantly Enhancing Detection Rate

  2021cites this paper
• Tumors Are Evolutionary Island-Like Ecosystems

  2021cites this paper
• Genomic Instability in Circulating Tumor Cells

  2020influential citation
• The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape

  2020cites this paper
• The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer

  2020cites this paper
• Nozzle-free droplet generation with focused acoustic beams for encapsulation of single circulating tumor cells

  2020cites this paper
• Biochemical reprogramming of tumors for active modulation of receptor-mediated nanomaterial delivery.

  2020cites this paper
• A Direct Comparison between the Lateral Magnetophoretic Microseparator and AdnaTest for Isolating Prostate Circulating Tumor Cells

  2020cites this paper
• Biopsia liquida: una review

  2019cites this paper
• Cell-free DNA as Diagnostic Markers

  2019influential citation
• Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks.

  2019cites this paper
• Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors

  2019cites this paper
• Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status

  2019cites this paper
• Liquid Biopsy in Solid Malignancy

  2019cites this paper
• Biophysical Insights on the Enrichment of Cancer Cells from Whole Blood by (Affinity) Filtration

  2019cites this paper
• Highlighting the uniqueness in dielectrophoretic enrichment of circulating tumor cells

  2019cites this paper
• The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells

  2019cites this paper
• Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.

  2019cites this paper
• Recent advances in microfluidic methods in cancer liquid biopsy.

  2019cites this paper
• The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor

  2019influential citation
• Progress in the polymer-paclitaxel conjugate

  2019cites this paper
• The pro-metastatic effects of hemodynamic shear stress : breast cancer cells acquire aggressiveness during circulation

  2018cites this paper
• Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review

  2018cites this paper
• CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer

  2018cites this paper
• Liquid biopsy for liver diseases

  2018cites this paper
• Circulating Tumor Cells: Applications in Cytopathology.

  2018cites this paper
• Determination of Circulating Tumor Cells by Flow Cytometry in the Bladder Cancer Patients

  2018cites this paper
• Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes

  2018cites this paper
• Cellular and molecular signature of oral squamous cell carcinoma

  2018cites this paper
• Why is Immunohistochemical Detection of Metastasized Breast Cancer Cells in the Immunocompetent Host Not Always Easy?

  2018cites this paper
• Revisiting the hallmarks of cancer.

  2017cites this paper
• Clinical Applications of and Challenges in Single-Cell Analysis of Circulating Tumor Cells

  2017cites this paper
• Hemodynamic shear stress stimulates migration and extravasation of tumor cells by elevating cellular oxidative level.

  2017cites this paper
• Performance of four modern whole genome amplification methods for copy number variant detection in single cells

  2017cites this paper
• High expression of LAMP2 predicts poor prognosis in patients with esophageal squamous cell carcinoma

  2017cites this paper
• Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells

  2017cites this paper
• Cancer stem cells: at the forefront of personalized medicine and immunotherapy.

  2017cites this paper
• Detection of single cell heterogeneity in cancer.

  2017cites this paper
• Nitric oxide is cytoprotective to breast cancer spheroids vulnerable to estrogen-induced apoptosis

  2017cites this paper
• Circulating miR-1826 in plasma correlates with circulating tumor cells and is a prognostic marker in colorectal cancer

  2017cites this paper
• Hyaluronic acid-functionalized electrospun PLGA nanofibers embedded in a microfluidic chip for cancer cell capture and culture.

  2017cites this paper
• Recent progress with next‐generation biomarkers in muscle‐invasive bladder cancer

  2017cites this paper
• Exosomes: A Cancer Theranostics Road Map

  2017cites this paper
• Altered expression of lysosomal associated membrane protein 1 in esophageal squamous cell carcinoma.

  2017cites this paper
• Circulating Tumor Cells: Fluid Surrogates of Solid Tumors.

  2017influential citation
• Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack

  2016cites this paper
• Liquid biopsy and NSCLC.

  2016cites this paper
• Lung Cancer Management Liquid biopsy and NSCLC

  2016cites this paper
• Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies

  2016cites this paper
• Dual-patterned immunofiltration (DIF) device for the rapid efficient negative selection of heterogeneous circulating tumor cells.

  2016cites this paper
• The development of a liquid biopsy for head and neck cancers.

  2016cites this paper